Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04786626
Other study ID # XH-21-002
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 20, 2021
Est. completion date December 31, 2023

Study information

Verified date January 2021
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact Xipeng Wang, Doctor
Phone 86-021-25078999
Email wangxipeng@xinhuamed.com.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cesarean scar defect is one of the complications after cesarean section (CSD). CSD may be further caused many long term complications, such as abnormal uterine bleeding, infertility, uterine scar pregnancy and uterine rupture. Vaginal repair due to CSDs is a minimally invasive and effective method that maintains fertility. The main concern linked to surgery is the quality of healing of the myometrial incision. However, no diagnostic method has yet been widely accepted to assess the healing process. Thus, the authors investigated uterine healing after vaginal repair with two-dimensional (2D) power Doppler ultrasound (PDU) in this study.


Description:

The inclusion criteria were CSD patients who had one or more cesarean deliveries, patients who had intermenstrual spotting after the cesarean section or those in which the thickness of the residual myometrium (TRM) was less than 3.0 mm at the preoperative stage. Patients who had a history of endocrine disorders, coagulation disorders, use of intrauterine devices, sub-mucous myoma, endometrial diseases, endometrial cysts, uterine fibroids, and adenomyosis after cesarean section were excluded from this study. After vaginal repair, all patients were followed by traditional 2D US scanning and Doppler velocimetry on Days: 0, 2, 30, 60 and 90. Authors evaluated: scar diameter and Doppler velocimetry and resistance index (RI) of the uterine arteries, at their ascending branch.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 31, 2023
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: 1. have one or more cesarean deliveries, 2. have intermenstrual spotting after the cesarean section or TRM was less than 3.0 mm at the preoperative stage 3. underwent MRI and TVS to evaluate the size of the defect and the TRM before surgery 4. have vaginal repair of CSD 5. write consent for operation. Exclusion Criteria: 1. have a history of endocrine disorders 2. have coagulation disorders 3. use of intrauterine devices 4. have sub-mucous myoma 5. have endometrial diseases 6. have endometrial cysts, uterine fibroids, and adenomyosis

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Ultrasound evaluation
After vaginal, all patients were followed by traditional 2D US scanning and Doppler velocimetry on Days: 0, 2, 30, 60 and 90. Authors evaluated: scar diameter and Doppler velocimetry and resistance index (RI) of the uterine arteries, at their ascending branch

Locations

Country Name City State
China Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other reproductive information reproductive information by questionnaire, including abortion, delivery, childbirth, etc. 2 years
Primary Ultrasound Evaluation resistance index (RI) of the uterine arteries Change from Baseline Systolic Blood Pressure at 6 months
Secondary the size of CSD the length in millimeters, the width in millimeters and the depth in millimeters of CSD on Days: 0, 2, 30, 60 and 90
Secondary the TRM of scar the TRM of scar on Days: 0, 2, 30, 60 and 90
See also
  Status Clinical Trial Phase
Recruiting NCT06375538 - Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy
Completed NCT04529837 - Ultrasound Assessment of DILAPAN-S
Completed NCT04208438 - Non-Invasive Jugular Venous Blood Volume Assessment (BVI)